关于糖尿病视网膜病变和黄斑病变的医疗和外科管理的最新信息
Yen-Ting Chen1, Nishant V Radke2, Sohani Amarasekera3
1Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan; Department of Ophthalmology, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
概括
糖尿病视网膜病变和糖尿病黄斑胀是导致视力丧失的主要原因. 本综述涵盖了医疗和外科治疗,风险因素,生物标志物以及糖尿病眼病管理的具有挑战性的手术病例.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 糖尿病视网膜病变 (DR) 和糖尿病黄斑 (DME) 是全球不可逆转的视力丧失的主要原因.
- 流行病学因地区,种族和城乡环境而异.
- 许多风险因素有助于DR的发展和进展.
研究的目的:
- 为DR和DME提供当前医疗和外科管理策略的全面审查.
- 突出流行病学数据,风险因素和DR的潜在生物标志物.
- 讨论复杂的糖尿病玻璃切除术的挑战和策略.
主要方法:
- 对DR和DME的医疗和外科治疗的文献综述.
- 对流行病学数据,风险因素和生物标志物的分析.
- 检查了手术技术和结果,以挑战糖尿病切除术.
主要成果:
- 医疗治疗包括抗VEGF药物,抗炎药物和生物仿制药.
- 晚期病例需要进行手术管理,特别是玻璃切除术.
- 具有挑战性的糖尿病玻璃切除术需要专门的技术来最大限度地减少并发症.
结论:
- 多学科的方法对于优化DR和DME患者的视觉结果至关重要.
- 需要对生物标志物和先进的外科手术技术进行持续的研究.
- 有效的DR和DME管理可以改善患者的生活质量.
相关概念视频
Diabetes: Management and Pharmacotherapy
222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222
Glaucoma: Overview
493
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
493
Open Angle Glaucoma: Treatment
383
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
383


